Martha Goldberg Aronson - 07 Feb 2022 Form 4 Insider Report for Cardiovascular Systems Inc

Role: Director
Signature: /s/ Andrew Nick as Attorney-in-Fact for Martha Goldberg Aronson pursuant to Power of Attorney previously filed.
Issuer symbol: N/A
Transactions as of: 07 Feb 2022
Net transactions value: +$46,075
Form type: 4
Filing time: 09 Feb 2022, 15:45:18 UTC
Previous filing: 11 Aug 2021
Next filing: 02 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CSII	Common Stock	Purchase	$46,075	+2,500	+33%	$18.43	10,000	07 Feb 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CSII	Restricted Stock Units						16,938	07 Feb 2022	Common Stock	16,938		Direct	F1
holding	CSII	Restricted Stock Units						2,411	07 Feb 2022	Common Stock	2,411		Direct	F2
holding	CSII	Restricted Stock Units						3,814	07 Feb 2022	Common Stock	3,814		Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership.
F2	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment, and shall be payable in cash or shares of Company common stock on the payment date.
F3	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 954 shares on each of September 30, 2021 and December 31, 2021 and as to 953 shares on each of March 31, 2022 and June 30, 2022.